EligibleTrials

Clinical trials recruiting for Cognitive Function

11
Recruiting trials
11
US states with sites
13
Countries
36%
Accept healthy volunteers

Phase breakdown

Phase 4 1Not applicable 10

Drugs and treatments being studied

InterventionTrials
Gadobenate dimeglumine1
Gadobutrol1
Gadodiamide1
Gadoterate meglumine1
Gadoteridol1
Gadoxetate disodium1
Protein supplementation with a plant-based protein isolate1
Protein supplementation with an animal-based protein isolate1

Where trials are recruiting (top US states)

StateRecruiting trials
Texas2
Arizona1
California1
Connecticut1
Florida1
Illinois1
Massachusetts1
Missouri1
North Carolina1
Pennsylvania1
Wisconsin1

Top cities

Arlington, Texas 1Boston, Massachusetts 1Chapel Hill, North Carolina 1Chicago, Illinois 1Dallas, Texas 1Hershey, Pennsylvania 1Houston, Texas 1Los Angeles, California 1Madison, Wisconsin 1Methuen, Massachusetts 1

Self-screener

Recruiting trials

Related conditions

Trials recruiting for Cognitive Function often also study these conditions. Each links to its own recruiting-trial list.

Depression 1463Anxiety 1237Sleep Quality 12Breast cancer 2239Urinary Incontinence 9Type 2 diabetes 891Sleep Hygiene 5Sedentary Behavior 11Sarcopenia 45Prostate cancer 1234

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Cognitive Function trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.